55
Participants
Start Date
November 30, 2007
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
rBet v 1
Two tablets (1 placebo + 1 rBet v 1 or 2 rBet v 1) were administered every day over 2 weeks with a 2-day break for the week-end. Administered doses ranged from 12.5 to 100 µg rBet v 1.
Placebo
Two matching placebo tablets were administered every day over 2 weeks with a 2-day break for the week-end.
National University Hospital - Allergy Unit 4222, Copenhagen
Lead Sponsor
Quintiles, Inc.
INDUSTRY
Stallergenes Greer
INDUSTRY